Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya.
BACKGROUND: Visceral leishmaniasis (VL) is a systemic parasitic disease that is fatal unless treated. In Kenya, national VL guidelines rely on microscopic examination of spleen aspirate to confirm diagnosis. As this procedure is invasive, it cannot be safely implemented in peripheral health structur...
Saved in:
Main Authors: | Jane Mbui (Author), Monique Wasunna (Author), Manica Balasegaram (Author), Adrian Laussermayer (Author), Rashid Juma (Author), Simon Njoroge Njenga (Author), George Kirigi (Author), Mark Riongoita (Author), Roberto de la Tour (Author), Joke van Peteghem (Author), Raymond Omollo (Author), François Chappuis (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
by: Ahmed M Musa, et al.
Published: (2010) -
Different liposomal amphotericin B formulations for visceral leishmaniasis
by: Thomas P C Dorlo, et al.
Published: (2014) -
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016) -
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
by: Ahmed Musa, et al.
Published: (2012) -
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
by: Asrat Hailu, et al.
Published: (2010)